Viking Therapeutics
VKTX
$76.97
Share price
1.60%
Change (1 day)
236.70%
Change (1 year)
Categories
Viking Therapeutics (VKTX) - Net assets
Net assets on the balance sheet as of March 2024 : $0.93 B
According to Viking Therapeutics
's latest financial reports the company has $0.93 B in net assets.
A company’s net assets is the sum of its assets minus the sum of its liabilities.
Viking Therapeutics - Net assets on balance sheet (from 2014 to 2024)
Net assets by year
| Year | Net assets | Change |
|---|---|---|
| 2023-12-31 | $0.34 B | 139.76% |
| 2022-12-31 | $0.14 B | -28.02% |
| 2021-12-31 | $0.20 B | -17.38% |
| 2020-12-31 | $0.24 B | -11.83% |
| 2019-12-31 | $0.27 B | -6.93% |
| 2018-12-31 | $0.29 B | 2111.45% |
| 2017-12-31 | $13.46 M | 67.4% |
| 2016-12-31 | $8.04 M | -7.82% |
| 2015-12-31 | $8.72 M | -139.43% |
| 2014-12-31 | $-22.13 M | 8730.08% |
| 2013-12-31 | $-0.26 M | 137.73% |
| 2012-12-31 | $-0.11 M |
Net assets for similar companies or competitors
| Company | Net assets | differencediff. | Country |
|---|---|---|---|
 Ultragenyx RARE | $0.27 B | -70.51% | 🇺🇸 USA |
 Repligen
RGEN | $1.97 B | 111.07% | 🇺🇸 USA |